Irvine Scientific Introduces Natural Killer Medium for Immunotherapy & Translational Research Applications
The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells
The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells
New collaboration with INRA Micalis-MGP will concentrate on DuPont’s probiotic strains and the understanding of these microbes’ mechanism of action on human health
AMSBIO’s new cell culture medium offers better conditions for induced pluripotent and embryonic stem cells, study shows
How cross-functional collaboration between academia and industry is advancing drug discovery in the ULTRA-DD program
The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy
Attend Miltenyi Biotec’s symposium to learn how researchers are tackling tumor heterogeneity with single-cell-analysis
Learn how to get the most from your scratch wound healing assays
To be in with a chance of winning a $500/£400/450€ Amazon voucher, just tell us which new product, instrument or consumable made the most difference to your lab in 2017
Which new product, instrument or consumable has made the most difference to your lab? Nominate now for a chance to win a $500 Amazon voucher
SelectScience is attending SLAS 2018 in San Diego, USA, where we will host the Scientists’ Choice Awards for Drug Discovery at our special 20th Anniversary Party
Register now to discover new, expert perspectives on process design, scale-up, and product safety
From cancer cells to ocean microbes to Zika virus: Read the interviews that made the most impact in 2017
In this webinar, experts discuss the important considerations to take into account when using biological buffers
Discover the latest releases, the hottest topics and the stand-out products of the 47th annual society for neuroscience meeting
University of Manchester and Orchard Therapeutics team up to treat Sanfilippo syndrome
Discover methods to advance the pre-clinical development of novel anti-cancer compounds